Transforming Healthcare with Patient360
Clinakos’ Integrated Patient Data is linked and curated from thousands of data sources from EHRs, lab results, imaging reports, SDOH, and patient-reported outcomes. This integrated approach enables a holistic Patient360 view of the patients to understand the full scope of a patient’s medical history, leading to more informed decisions and personalized care. With an integrated […]
Transforming Patient Outcomes
Did you know that the UK pays up to £30,000 per QALY (Quality Adjusted Life Year) for drugs used by their patients. In the US, organizations like ICER may evaluate the value of life-saving drugs, and the reimbursements can be even higher. Organizations like ISPOR—The Professional Society for Health Economics and Outcomes Research and Medical […]
Stanford University and US DOJ’s “The Promoting Competition in AI” Event
Thank you Stanford University and US DOJ for inviting me to join the “The Promoting Competition in AI” event co-hosted by the U.S. Department of Justice and the Stanford Institute for Economic Policy Research, yesterday, May 30th. Event speakers & attendees included top US, European and UK governmental agency heads; DOJ, US PTO, CMS & […]
ISPOR24 Was Wrapped up with Many Invaluable Insights
ISPOR24 came to a completion yesterday and completely lived up to its reputation of being the top global event for Health Economics and Outcomes Research (HEOR) professionals. The event started with the first of its kind workshop focused “Patient-Centered Research Summit 2024”. Clinakos Inc. attended with other attendees from key institutions like FDA and PCORI, […]
Meet us at ISPOR 2024
ISPOR—The Professional Society for Health Economics and Outcomes Research 2024 is just around the corner, set to take place in Atlanta from May 5-8, 2024. Discover how Clinakos Inc. leverages Integrated Patient Data™ and Medically Smart AI™, alongside our access to unique patient cohorts, to deliver innovative solutions for life sciences teams. One of the eagerly […]
Asembia’s AXS24 Summit is coming up soon
Asembia’s AXS24 Summit is coming up soon in Las Vegas from April 28 to May 2, 2024. Explore how Clinakos Inc. utilizes Integrated Patient Data™ and Medically Smart AI™, along with our access to niche patient populations to provide novel solutions for life sciences teams. If you’re interested in learning more or connecting with Clinakos, […]
Over 2400 participants came together at Word Orphan Drug Congress USA
The World Orphan Drug Congress USA unfolds today at the Boston Convention and Exhibition. With over 2,400 participants coming together, the main theme of “Breaking down silos and fostering collaboration to help rare disease patients” sets the stage for impactful discussions. The conference will talk about various interesting topics including advanced therapies in commercialization and […]
A Remarkable Gathering at AMCP 2024 in New Orleans
With the wrap up of AMCP 2024 in New Orleans, we are thrilled to observe how the conference themes aligned so deeply with Clinakos Inc.‘s mission to better healthcare outcomes and patient care. The conference was a catalyst for progress and collaboration in advancing better therapies & patent outcomes, mirroring Clinakos’ relentless pursuit of advancing […]
Leveraging AI/ML to Improve Marketing Effectiveness in Rare Disease & Beyond
“Leveraging AI/ML to Improve Marketing Effectiveness in Rare Disease & Beyond” from Clinakos Inc., Chiesi Global Rare Diseases and Real Chemistry received a lot of interest at the Intellus Worldwide annual conference last week. Lisa Griffith opened the presentation with Inder Jaggi and Araba Nti taking turns showcasing multiple case studies that highlighted actionable insights […]
Inder Jaggi, CEO of Clinakos, Invited by Stanford University Graduate School of Business
Clinakos Inc. CEO Inder Jaggi joined other CEOs, philanthropists, and leaders invited by Stanford University Graduate School of Business at its one-of-a-kind “Business, Government, and Society Forum” on April 3, 2024. Speakers included Stanford GSB dean and now the president of Stanford University Jon Levin, CEO of Google Sundar Pichai, Chairman of the US Federal […]
